Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gestodene/EE patch for contraception
NCT00910637Phase 3Completed
- Sponsor
- Bayer
- Start
- May 2009
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of gestodene and ethinyl estradiol in contraception, sponsored by Bayer. Primary endpoint: Occurrence of pregnancy. Started May 2009; status: completed.
02
Drugs
gestodeneethinyl estradiol
03
Conditions
contraception
Beyond the preview
Go deeper on NCT00910637.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00910637.